ReviewInternational journal of nanomedicine2026
Recent Advances in Antitumor Nanomedicine Based on Covalent Organic Frameworks.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer remains one of the leading threats to human health today. With the rapid advancement of nanotechnology, the integration of nanomaterials with therapeutic strategies has shown great potential in addressing the limitations of conventional cancer treatments. Covalent organic frameworks (COFs) are novel crystalline porous polymers with well-defined backbones and nanopores, mainly composed of light elements (H, B, C, N, and O) linked by dynamic covalent bonds. Owing to their tunable morphology, adjustable porosity, intelligent responsive release, and good biocompatibility, COFs have been extensively explored for applications in cancer diagnosis and treatment. This review summarizes recent progress in the synthesis of COFs, their distinctions from other traditional nanomaterials, their tumor microenvironment-responsive release capabilities, and highlights the development of multifunctional COF-based nanoplatforms for cancer imaging and treatment. Finally, the prospects and challenges of COF-based nanoplatforms in tumor therapeutics are discussed, aiming to provide new diagnostic and therapeutic strategies for subsequent tumor prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.